Exagen Inc
XGN
NASDAQ
Biotechnology
$6.66
USD
+0.08 (+1.22%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $159.21M
Volume 154.2K
Price Target
$8.00 – $9.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $9.00 and a min estimate of $8.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$8.50
-$0.7 vs prior
Implied Upside
+27.6%
-10.5% vs prior
Analyst Covering
2
-3 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
29%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Mark Massaro | BTIG | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Max Masucci | Roth Capital | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
INDP
Indaptus Therapeutics Inc
$1.07
▲ +0.9%
GNLX
Genelux Corp
$2.74
▲ +4.2%
CADL
Candel Therapeutics Inc
$11.72
▼ -0.7%
COYA
Coya Therapeutics Inc
$4.79
▲ +2.6%
ANIX
Anixa Biosciences Inc
$3.18
▼ -0.6%
INO
Inovio Pharmaceuticals Inc
$1.09
▲ +21.1%
FBIO
Fortress Biotech Inc
$2.93
▼ -1.7%
BDTX
Black Diamond Therapeutics Inc
$2.02
▲ 0.0%